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Abstract
Background/Aims: Preterm birth (PTB) and low birth weight (LBW) significantly influence 
mortality and morbidity of the offspring in early life and also have long-term consequences in 
later life. A better understanding of the molecular mechanisms of preterm birth could provide 
new insights regarding putative preventive strategies. Metabolomics provides a powerful 
analytic tool to readout complex interactions between genetics, environment and health and 
may serve to identify relevant biomarkers. In this study, the association between 163 targeted 
maternal blood metabolites and gestational age was investigated in order to find candidate 
biomarkers for PTB. Methods: Five hundred twenty-three women were included into this 
observational study. Maternal blood was obtained before delivery. The concentration of 163 
maternal serum metabolites was measured by flow injection tandem mass spectrometry. 
To find putative biomarkers for preterm birth, a three-step analysis was designed: bivariate 
correlation analysis followed by multivariable regression analysis and a comparison of 
mean values among gestational age groups. Results: Bivariate correlation analysis showed 
that 2 acylcarnitines (C16:2, C2), 1 amino acids (xLeu), 8 diacyl-PCs (PCaaC36:4, PCaaC38:4, 
PCaaC38:5, PCaaC38:6, PCaaC40:4, PCaaC40:5, PCaaC40:6, PCaaC42:4), and 1 Acylalkyl-PCs 
(PCaeC40:5) were inversely correlated with gestational age. Multivariable regression analysis 
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pressure at the third trimester, and maternal body weight at the third trimester, showed that 
the diacyl-PC PCaaC38:6 was the only metabolite inversely correlated with gestational age. 
Conclusions: Maternal blood concentrations of PCaaC38:6 are independently associated with 
gestational age.
© 2016 The Author(s)
Published by S. Karger AG, Basel
Introduction
Preterm birth (PTB), defined as birth before 37th week of gestation, affects 5 to 18% 
of pregnancies worldwide. Evidence suggests that PTB not only significantly influences 
mortality and morbidity of the offspring in early life [1-7] but also causes serious long-term 
consequences in later life [8-11]. Systematic reviews and meta-analyses including large 
populations and different separate cohorts demonstrated that PTB increased the risk of 
metabolic syndrome at later childhood and adulthood [8-10]. Sensitive, effective, and non-
invasive new biomarkers to screen and diagnose PTB before birth could lead to treatment 
options that prevent poor birth outcomes associated with PTB. Pregnancy is a very complex 
process, influenced by a plethora of physiological and pathophysiological factors. It is known 
that environmental factors like maternal infections, nutrition, and stressful events can be 
associated with changes in the serum metabolite profile. Metabolomics provides a powerful 
analytic tool to get insights into the complex interaction of genetics, environment and health 
and may serve to identify relevant predictive biomarkers for PTB. Previous work from 
Romero et al. [12] and Menon et al. [13] showed that the metabolomic profile of amniotic fluid 
is a good biomarker to assess the risk of preterm delivery. However, amniotic fluid sample 
collection is an invasive procedure with potential risk for adverse outcomes for both mother 
and child [14,15]. Blood plasma and (or) urine can be collected much easier and therefore 
should be targeted in the search of potential biomarkers. One recent study demonstrated that 
the maternal urinary metabolic profile in early pregnancy can be helpful to identify PTB [16]. 
So far, there is no publication about the metabolomic profile of maternal plasma and PTB. In 
this study, a targeted metabolomics approach was performed, measuring 163 metabolites 
which were analyzed for associations with gestational age. The detection of new biomarkers 
predictive for PTB could help to better understand the underlying pathomechanisms of PTB 
and to create new preventive strategies for PTB.
Materials and Methods
Clinic data collection
This observational study was approved by the local Ethics Committee. A total of 550 pregnant women 
who delivered their babies at the Charité obstetrics department in Berlin, Germany between January 2007 
and December 2008 were invited to participate. As 27 mothers were excluded from the study because they 
delivered twins, 523 women entered the study. The majority of the mothers (n = 471) were of caucasian 
ethnicity, the others had an African, Asian, or Arabic background.
After written consent was obtained, a structured medical history was taken. The following data were 
extracted into our database: age, ethnicity, body height, body weight before pregnancy, gravidity, parity, 
diabetes mellitus and hypertension during pregnancy, smoking status before and during pregnancy, systolic 
and diastolic blood pressure (BP) measurements recorded during pregnancy and the mode of delivery. 
Biometric data of the newborn were collected during the routine postnatal examination: birth weight, birth 
length, head circumference, child sex, and Apgar score 5 minutes postnatally and Apgar score 10 minutes 
postnatally. Gestational age at delivery was based on last menstrual period, anamnestically assessed during 
the first pregnancy examination.
Sample collection, blood metabolomics compounds assay
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data were expressed as arithmetic mean ± standard error (SE). Bivariate Correlation Analysis was applied 
to detect correlations of metabolites and gestational age. Additionally, certain factors (PTB history, maternal 
BMI before pregnancy, systolic blood pressure at the third trimester, maternal body weight at the third 
trimester) were used as confounders to calculate and adjust putative predictive metabolites in multivariable 
linear regression models. Unpaired t-test was used for comparison of continuous variables between two 
groups. A p-value less than 0.05 was considered significant. 
Results
Description of the cohort
Descriptive data of the study population are given in table 1. The study population 
represented a typical German birth cohort in regards to key characteristics like maternal 
age, ethnicity, BMI before pregnancy, gravidity, parity, biometric data of the newborns like 
birth weight, birth length, child sex, and Apgar score (for more details, see Table 1). The 
distribution of gestational age is given in Figure 1.
Bivariate correlation analyses of maternal serum metabolites and gestational age 
 Bivariate correlation analyses showed that 2 acylcarnitines (C16:2, C2), 1 amino acid 
(xLeu), 8 diacyl-PCs (PCaaC36:4, PCaaC38:4, PCaaC38:5, PCaaC38:6, PCaaC40:4, PCaaC40:5, 
PCaaC40:6, PCaaC42:4), and 1 acylalkylphosphatidylcholine (PCaeC40:5) were significantly 
negatively correlated with gestational age (for more details, see table 2). 
Multivariable regression analyses of maternal blood metabolites and gestational age 
Significant results obtained by bivariate correlation analysis were subsequently analy-
Table 1. Detailed Descriptive Data of the Mother/Child Pairs (n = 523)birth, before the usage of oxytocin, 
or analgesics. Blood was centrifuged 
at 2750 g immediately after its 
taking and the obtained serum was 
stored at -80 °C until measurements 
were performed. 
163 targeted small metaboli-
tes were quantified simultaneously 
in 10 µL of serum using the Abso-
lute IDQTM-kit p150 (Biocrates 
Life Sciences AG, Innsbruck, Aus-
tria). The assay procedures were 
the same as previously described 
[17]. Concentrations of these tar-
geted metabolites were recorded 
in μM. These metabolites included 
14 amino acids, 1 sugar, 1 carnitine, 
26 acylcarnitines, 14 hydroxy and 
dicarboxy-acylcarnitines, 10 sphin-
gomyelins, 5 hydroxy-sphingomye-
lins, 38 diacyl-phosphatidylcholines 
(diacyl-PCs), 39 acyl-alkyl-phospha-
tidylcholines (Acylalkyl-PCs) and 15 
lysophosphatidylcholines. 
Statistical analysis
Data were analyzed with SPSS 
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zed by multivariable regres-
sion analysis considering 
PTB history, maternal BMI 
before pregnancy, systolic 
blood pressure at the third 
trimester, maternal BMI at 
the third trimester in mo-
del B. Analysis showed that 
PCaaC38:6 was the only me-
tabolite significantly inver-
sely correlated with gesta-
tional age (for more details, 
see table 3).
PCaaC38:6 serum con-
centrations in relation 
to gestational age 
2 gestational age 
groups were stratified as 
follows: gestational age < 
37weeks as group 1 (PTB 
group), ≧ 37 weeks as group 
2. The PTB group displayed 
significantly higher con-
centrations of PCaaC38:6 
in comparison to group 2 
(100.09 ± 4.22 μM vs. 89.66 
± 1.17μM, P = 0.023);
4 gestational age 
groups were stratified as 
follows: gestational age < 
35 weeks as group 1 (se-
vere PTB group), 35~37 
weeks as group 2 (moderate 
PTB group), 38~39 weeks 
as group 3, ≧ 40 weeks as 
group 4. PCaaC38:6 showed 
a trend to decrease with in-
creasing gestational age (for 
more details, see figure 2).
Discussion
Fig. 1. Distribution of gestational age.
Table 2. Maternal serum metabolites related to gestational age in biva-
riate correlation analysis
In the current birth cohort study, the association of 163 maternal serum metabolites 
and gestational age before delivery was investigated. Diacyl phosphatidylcholine PCaaC38:6 
was strongly and inversely correlated with gestational age. Concentration of PCaaC38:6 was 
significantly higher in serum of mothers with PTB than in the serum of mothers who gave 
birth between 37th and 40th or above 40th week of gestation. This indicates that unsaturated 
diacyl-PCs (PCaaC38:6) might be candidate biomarkers for PTB screening and monitoring.
In recent years, elaborate molecular biologic methods like genomics, transcriptomics, 
and proteomics have been used to study normal pregnancy and pregnancy complications. 
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collected amniotic fluid from transabdominal amniocentesis at the time of diagnosis for 
preterm labor and showed that mothers without intraamniotic infection/inflammation who 
delivered preterm had a relative decrease in carbohydrates and amino acids. In contrast, 
mothers with intraamniotic infection/inflammation had a more substantial decrease in 
compounds of the carbohydrate cluster, and a relative increase in amino acids. Menon et 
al. [13] collected amniotic fluid from transvaginal amniocentesis samples taken prior to 
delivery during active labor in an African-American population and found that the global 
metabolite profiles differed significantly between normal and preterm birth. Many of the 
significantly altered metabolites in the PTB group reflected liver metabolism. Different to 
previous studies, the current study investigated maternal metabolites in serum obtained 
before delivery in a typical German cohort. Statistical analyses showed that maternal plasma 
phospholipids (six Diacyl-PCs and two Acylalkyl-PCs), especially PCaaC38:6, are relevant to 
PTB.
Glycerophospholipids make up the main structural lipids of cellular membranes, 
and phosphatidylcholine (PC) accounts for >50% of the glycerophospholipids in most 
eukaryotic membranes [18, 19]. PC is the main component of circulating lipoprotein classes 
in the human plasma [20]. In addition, PC is particularly essential for hepatic secretion of 
Fig. 2. Mean maternal PCaaC38:6 according to gestational age groups. A: 2 gestational age groups were 
stratified as follows: <37 weeks with 57 cases, ≧ 37 weeks with 466 cases. B: 4 gestational age groups were 
stratified as follows: <35 weeks with 29 cases, 35~37 weeks with 73 cases, 38~39 weeks with 233 cases, ≧ 
40 weeks with 188 cases.
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triglyceride-rich very low density lipoprotein (VLDL) and high density lipoprotein (HDL) 
[19]. PC is essential for proper cell division and thus plays a very important role during 
fetal intrauterine growth. Furthermore, PC is the main source of choline which is essential 
for fetal brain and neurocognitive development [21,22]. Bernhard et al. [23] showed that in 
preterm infants, choline concentrations are lower in postnatal plasma than in cord plasma. 
La et al [24] conducted an S-plot for biomarkers of gestational age (PCs, PEs, and SMs) and 
showed that they had a weak, negative correlation with gestational age. Till now, there is no 
data available that links diacyl-PCs to gestational physiological or pathological conditions.
The most common phenotype of PTB is spontaneous PTB of unknown etiology. Risk 
factors of PTB include malnutrition, obesity, intra-amniotic infection (IAI) and inflammation, 
cigarette smoking, alcohol intake, drug use, antioxidant deficient diets, physiologic and 
psycho-social stressors, environmental pollutants, genotoxic agents, geographic location [25]. 
All of the PTB risk factors are capable of causing redox imbalances, leading to the production 
of superoxide, hydrogen peroxide, hydroxyl ions and nitric oxide that can damage collagen 
matrix and consume antioxidant defenses. These events can trigger uterine contractions 
(labor), leading to PTB and placing these infants at a higher risk of injury [25]. Recently, a 
large cohort study with 18,079 participants (KORA study) and seven years follow-up [26] 
showed that compared with former smokers and never smokers, current smokers had higher 
concentrations of unsaturated diacyl-PCs but lower concentrations of saturated diacyl-PC. It 
has been shown that unsaturated fatty acids are more vulnerable to lipid peroxidation [27-
29]. Furthermore, polyunsaturated diacyl-PCs can promote the oxidation and fragmentation 
of γ-hydroxyalkenals [29]. Oxidative stress (OS) can occur early in pregnancy [30], induce 
pregnancy-related disorders like preeclampsia [31-33] and  preterm premature rupture of 
membranes [34-36], and is considered a detrimental factor in preterm birth pathology [25]. 
Results of the current study showed that unsaturated diacyl-PCs (PCaaC36:4, PCaaC38:4, 
PCaaC38:5, PCaaC38:6, PCaaC40:4, PCaaC40:5, PCaaC40:6, PCaaC42:4), especially 
PCaaC38:6, were negatively correlated with gestational age. Higher unsaturated diacyl-PCs 
may be indicative of a higher level of OS. Future studies, including animal experiments and 
human epidemiological studies are needed to confirm the relationship between diacyl-PCs 
and OS.
One limitation of the study is that maternal serum metabolites were only measured 
prior to birth. Given that a predictive biomarker for PTB could be of great clinical significance, 
the current results should stimulate studies, which focus on measuring serum metabolites at 
multiple and/or earlier occasions in order to consider a potential gestational age dependent 
secretion of the metabolomic biomarkers. In particular the lipid biomarkers identified in 
the current study need confirmation in a second independent prospective study. Moreover, 
our work should stimulate preclinical work using specific tools to block and up-regulate 
the biological action of PCaaC38:6 to reveal causality and biological relevance between 
PCaaC38:6 and PTB.
Conclusion
Maternal blood PCaaC38:6 was clearly correlated with gestational age. PCaaC38:6 may 
be a candidate biomarker for PTB.
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